Related Experiment Video
Updated: Jan 16, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Intravesical Bacillus Calmette-Guérin (BCG) Immunotherapy-Related Pneumonitis: A Case Report
Nevra Gullu Arslan1, Sengul Aksakal2
1Department of Pulmonary Medicine, Samsun Education and Research Hospital, Samsun, TUR.
Abstract:
Intravesical bacillus Calmette-Guérin (BCG) immunotherapy is widely used as a standard adjuvant treatment for non-muscle invasive bladder cancer. The exact mechanism of BCG action and the mechanisms responsible for early and late complications after intravesical BCG treatment remain poorly understood, and it is still unclear in which patients local or systemic adverse effects will develop. The patient who received intravesical BCG treatment for six weeks presented with complaints of arthralgia, loss of appetite, fatigue, and intermittent low-grade fever. High-resolution chest computed tomography showed bilateral ground-glass opacities and showed no response to antiviral or antimicrobial treatments. Bronchoalveolar lavage flow cytometry demonstrated a markedly elevated CD4/CD8 ratio (6:1). Based on clinical, radiologic, and immunologic findings, pneumonitis secondary to BCG-related inflammation (BCG-itis) was diagnosed. Differentiating infectious from immune-mediated adverse events in BCG-itis can be challenging.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

